[{"AccountsPayableCurrent_0_Q1_USD":9534000.0,"ContractWithCustomerLiability_0_Q1_USD":127510000.0,"ContractWithCustomerAssetReclassifiedToReceivable_1_Q1_USD":3000000.0,"ContractWithCustomerAssetGrossCurrent_0_Q1_USD":990000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":71074000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":3122000.0,"RevenueRemainingPerformanceObligation_0_Q1_USD":127500000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q1_shares":1428000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_1_Q1_USD":-3267000.0,"MarketableSecurities_0_Q1_USD":0.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":1489000.0,"ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_1_Q1_USD":283000.0,"IncrementalCommonSharesAttributableToConversionOfDebtSecurities_1_Q1_shares":501000.0,"ConvertibleDebtNoncurrent_0_Q1_USD":2082000.0,"AccountsReceivableGrossCurrent_0_Q1_USD":54000.0,"UnbilledReceivablesCurrent_0_Q1_USD":1753000.0,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":3047000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":78000.0,"IncreaseDecreaseInContractWithCustomerAsset_1_Q1_USD":-2641000.0,"ProceedsFromSaleOfMachineryAndEquipment_1_Q1_USD":1426000.0,"GainLossOnSaleOfPropertyPlantEquipment_1_Q1_USD":709000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":240000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":529000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":5211000.0,"InterestExpenseDebt_1_Q1_USD":24000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":123000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":283000.0,"PaymentsOfStockIssuanceCosts_1_Q1_USD":229000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.11,"OperatingLeaseRightOfUseAsset_0_Q1_USD":15234000.0,"OperatingLeasePayments_1_Q1_USD":1400000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":20996000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":3071000.0,"OperatingLeaseLiability_0_Q1_USD":24067000.0,"NumberOfOperatingSegments_1_Q1_item":1.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":8616000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":4125000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":127387000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":5323000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":5510000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":5470000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":6866000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":32683000.0,"InvestmentIncomeNet_1_Q1_USD":646000.0,"FinanceLeaseLiability_0_Q1_USD":0.0,"DeferredFinanceCostsNoncurrentNet_0_Q1_USD":18000.0,"DeferredFinanceCostsCurrentNet_0_Q1_USD":557000.0,"DebtInstrumentConvertibleNumberOfEquityInstruments_1_Q1_USD":501000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_1_Q1_USD":null,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":5389000.0,"RestructuringCharges_1_Q1_USD":825000.0,"OperatingLeaseExpense_1_Q1_USD":1000000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q1_USD":13287000.0,"ProfitLoss_1_Q1_USD":-29088000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":97744000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":7653000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":21000.0,"NetIncomeLoss_1_Q1_USD":-29088000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-28315000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":1405000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":97984000.0,"LiabilitiesCurrent_0_Q1_USD":85506000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":298809000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":6018000.0,"Liabilities_0_Q1_USD":302912000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-7446000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-649000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":8864000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.17,"CommonStockValue_0_Q1_USD":1743000.0,"CommonStockSharesOutstanding_0_Q1_shares":174261000.0,"CommonStockSharesIssued_0_Q1_shares":174261000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":247299000.0,"AssetsCurrent_0_Q1_USD":270726000.0,"Assets_0_Q1_USD":298809000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":2228000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-29088000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1316556000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":166947000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":1310710000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":18916000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":97744000.0,"OtherAssetsNoncurrent_0_Q1_USD":6831000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":250000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-198000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":86000.0,"ShareBasedCompensation_1_Q1_USD":3122000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":27408000.0,"PreferredStockValue_0_Q1_USD":null,"StockholdersEquity_0_Q1_USD":-4103000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"OperatingIncomeLoss_1_Q1_USD":-23810000.0,"OperatingExpenses_1_Q1_USD":37097000.0,"IncreaseDecreaseInOtherAccruedLiabilities_1_Q1_USD":5253000.0,"DebtInstrumentInterestRateStatedPercentage_0_Q1_pure":0.045,"ConvertibleNotesPayable_0_Q1_USD":2100000.0,"CommonStockSharesAuthorized_0_Q1_shares":200000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"CommitmentsAndContingencies_0_Q1_USD":null,"PreferredStockSharesIssued_0_Q1_shares":0.0,"VariableLeaseCost_1_Q1_USD":3100000.0,"Ticker":"IMGN","CIK":"855654","name":"IMMUNOGEN, INC.","OfficialName":"ImmunoGen Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1148965984.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200505"}]